Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
US11066417B2 · kind B2 · utility
8Cited by
8References
47Claims
0Family size
Assignee
Inventors
- Jeremy J. Clemens
- Alexander Russell Abela
- Corey Anderson
- Brett B. Busch
- Weichao George Chen
- Thomas Cleveland
- Timothy Richard Coon
- Bryan A. Frieman
- Senait G. Ghirmai
- Peter Diederik Jan Grootenhuis
- Anton V. Gulevich
- Sara S. Hadida Ruah
- Clara Kuang-Ju Hsia
- Ping Kang
- Haripada Khatuya
- Jason McCartney
- Mark Miller
- Prasuna Paraselli
- Fabrice Pierre
- Sara E. Swift
- Andreas P. Termin
- Johnny Uy
- Carl V. Vogel
- Jinglan Zhou
Key dates
| Filing date | Feb 14, 2019 |
| Grant date | Jul 20, 2021 |
| Priority date | — |
| Expiry date | Feb 14, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D515/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Formula (I): pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.